The safety and tolerability of berdazimer gel 10.3% in Japanese patients with molluscum contagiosumCapsule Summary

• Main Authors: Makoto Kawashima, MD, PhD (Author), Yoshiyuki Kaneko, BS (Author), Manami Sawasaki, BS (Author), Kyohei Masubuchi, BS (Author), Hiroyuki Yasukawa, BS (Author), Saki Okada, BS (Author), Carolyn Enloe, MPH (Author), Carri Geer, PhD (Author), Martina Cartwright, PhD (Author), Tomoko Maeda-Chubachi, MD, PhD (Author), Takeshi Tani, BS (Author)
• Format: Book
• Published: Elsevier, 2025-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Molluscum contagiosum (MC) is a contagious viral skin infection. Berdazimer gel, 10.3% (SB206 12%) is approved in the United States as the first topical, at-home MC prescription medication. Objective: To assess safety and tolerability of SB206 12% in Japanese patients with MC. Methods: S...